These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 20795590)
1. Treatment settings and metabolic monitoring for people experiencing first-episode psychosis. Batscha C; Schneiderhan ME; Kataria Y; Rosen C; Marvin RW J Psychosoc Nurs Ment Health Serv; 2010 Sep; 48(9):44-9. PubMed ID: 20795590 [TBL] [Abstract][Full Text] [Related]
2. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents. Schneiderhan ME; Batscha CL; Rosen C Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia. Brunero S; Lamont S; Fairbrother G Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781 [TBL] [Abstract][Full Text] [Related]
4. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications. Hasnain M; Vieweg WV; Fredrickson SK; Beatty-Brooks M; Fernandez A; Pandurangi AK Prim Care Diabetes; 2009 Feb; 3(1):5-15. PubMed ID: 19083283 [TBL] [Abstract][Full Text] [Related]
5. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Barnes TR; Paton C; Hancock E; Cavanagh MR; Taylor D; Lelliott P; Acta Psychiatr Scand; 2008 Jul; 118(1):26-33. PubMed ID: 18582345 [TBL] [Abstract][Full Text] [Related]
6. Metabolic abnormalities in an early psychosis service: a retrospective, naturalistic cross-sectional study. Curtis J; Henry C; Watkins A; Newall H; Samaras K; Ward PB Early Interv Psychiatry; 2011 May; 5(2):108-14. PubMed ID: 21470374 [TBL] [Abstract][Full Text] [Related]
10. Who should swing the stethoscope? An audit of baseline physical examination and blood monitoring on new patients accepted by an early intervention in psychosis team. Crabb J; McAllister M; Blair A Early Interv Psychiatry; 2009 Nov; 3(4):312-6. PubMed ID: 22642736 [TBL] [Abstract][Full Text] [Related]
11. Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring. De Hert M; van Eyck D; De Nayer A Int Clin Psychopharmacol; 2006 Mar; 21 Suppl 2():S11-5. PubMed ID: 16601508 [TBL] [Abstract][Full Text] [Related]
13. The incidence of metabolic risk factors in an inpatient psychiatric setting. Coakley C; Bolton P; Flaherty L; Kopeski LM; Slifka K; Sutherland MA J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):24-30. PubMed ID: 22329619 [TBL] [Abstract][Full Text] [Related]
14. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. Holt RI; Abdelrahman T; Hirsch M; Dhesi Z; George T; Blincoe T; Peveler RC J Psychopharmacol; 2010 Jun; 24(6):867-73. PubMed ID: 19304868 [TBL] [Abstract][Full Text] [Related]
16. Impact of a metabolic screening bundle on rates of screening for metabolic syndrome in a psychiatry resident outpatient clinic. Wiechers IR; Viron M; Stoklosa J; Freudenreich O; Henderson DC; Weiss A Acad Psychiatry; 2012 Mar; 36(2):118-21. PubMed ID: 22532201 [TBL] [Abstract][Full Text] [Related]
18. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes. Edward KL; Rasmussen B; Munro I Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688 [TBL] [Abstract][Full Text] [Related]
19. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients. Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the initial treatment phase in first-episode psychosis. Power P; Elkins K; Adlard S; Curry C; McGorry P; Harrigan S Br J Psychiatry Suppl; 1998; 172(33):71-6. PubMed ID: 9764130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]